← Back
Data updated: Mar 29, 2026
DURAMED PHARMS BARR
CardiovascularNeurologyDermatology
Generics
DURAMED PHARMS BARR is a generic drug manufacturer focused on Cardiovascular, Neurology, Dermatology.
1983
Since
35
Drugs
-
Trials
392
Approved (2yr)
Key Drugs
No active drugs
Top Drug Revenues Pro
Loading...
Revenue Over Time Pro
Loading...
Recent Activity
PROPRANOLOL HYDROCHLORIDE 2026-01-27
OXYCODONE AND ACETAMINOPHEN 2026-01-12
Labeling
OXYCODONE AND ACETAMINOPHEN 2026-01-06
Labeling
LOPERAMIDE HYDROCHLORIDE 2025-12-29
OXYCODONE AND ACETAMINOPHEN 2025-12-29
Labeling
OXYCODONE AND ACETAMINOPHEN 2025-12-29
Labeling
OXYCODONE AND ACETAMINOPHEN 2025-12-29
Labeling
OXYCODONE AND ACETAMINOPHEN 2025-12-23
Labeling
SEC Filings
Pro
Loading...
Therapeutic Areas
Score weights: Approved drugs ×3, Phase 3 ×2, Phase 2 ×1, Phase 1 ×0.5
Cardiovascular 50%
2 drugs
Neurology 25%
1 drugs
Dermatology 25%
1 drugs
Pipeline Forecast
Loading...
Loading...
Upcoming Trial Milestones Pro
Loading...
Patent Cliff Pro
Loading...
Loading...
Loading...
Competitors by Therapeutic Area
Active (13)
Discontinued (21)
OXYCODONE AND ACETAMINOPHEN ACETAMINOPHEN AND CODEINE PHOSPHATE MEPERIDINE HYDROCHLORIDE HALOPERIDOL PREDNISONE METHYLPREDNISOLONE PHENTERMINE HYDROCHLORIDE INDOMETHACIN MEDROXYPROGESTERONE ACETATE ISONIAZID CLONIDINE HYDROCHLORIDE TEMAZEPAM METHYLDOPA ESTROPIPATE AMINOPHYLLINE AVIANE-21 ENPRESSE-21 CYPROHEPTADINE HYDROCHLORIDE TOLAZAMIDE GYNODIOL PROPRANOLOL HYDROCHLORIDE & HYDROCHLOROTHIAZIDE
Company Info
- First Approval
- 1983-03-17
- Latest
- 2024-05-31
- Applications
- 68